Position in OVID
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,101,527
+$456,769 QoQ
Shares Held
409,490
+41.0% QoQ
Ownership
0.210%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 130 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. OVID ranks #213 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in OVID
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,101,527 | 409,490 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $644,758 | 290,432 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $317,686 | 194,900 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $471,518 | 362,707 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $4,919 | 14,908 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,905 | 31,750 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $52,987 | 56,733 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $44,712 | 37,892 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,711 | 29,534 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $56,692 | 18,588 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $174,871 | 54,308 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $152,431 | 39,696 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $171,907 | 52,411 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $33,828 | 13,112 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,392 | 3,437 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $21,621 | 11,751 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $35,060 | 16,307 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $130,617 | 41,598 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,530 | 1,723 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $113,137 | 33,672 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $270,188 | 69,102 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $90,143 | 22,424 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $35,571 | 15,399 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $128,638 | 22,411 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $153,937 | 20,887 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $143,606 | 48,190 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||